Skip to main content

MoneyWorks4Me

Ajanta Pharma informs about substantial acquisition of shares & takeovers

14 Jul 2026 Evaluate
Ajanta Pharma has informed that it enclosed Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 14, 2026 for Ravi Agrawal, trustee Ravi Agrawal Trust.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1869.50
Dr. Reddys Labs. 1370.40
Cipla 1394.00
Lupin 1977.90
Zydus Lifesciences 1200.25
View more..